Caged Antisense Oligonucleotide for RNA Capture in Fixed Tissue

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating and analyzing mRNA from single cells, especially in live tissue, are limited by the inability to effectively detect or compare nucleic acid molecules longitudinally or among different cells or subcellular compartments, and fixed tissue samples are compromised due to RNA crosslinking, lacking comprehensive RNA fingerprint analysis.

Innovation Solution

A caged molecule comprising an antisense oligonucleotide linked to a ruthenium-based photolinker is used, which, upon irradiation, exposes the oligonucleotide to hybridize with nucleic acids, allowing for the capture and isolation of various RNA species, including microRNAs and mRNA, from both live and fixed tissue samples.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If fixed tissue samples are used for molecular analysis, then tissue preservation is improved, but RNA analysis capability deteriorates due to crosslinking

Engineering Contradiction:
Improvetissue preservationVSAvoidRNA analysis capability
Core Design Contradiction:
Stability of the object's compositionVSReliability

Solution Approach 1:

The patent introduces a caged molecule that is pre-administered to the tissue sample before fixation. This molecule remains inactive during the fixation process and only becomes active after fixation is complete, allowing RNA capture to occur on fixed tissue without being compromised by the fixation-induced crosslinking.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The caged molecule acts as an intermediary that bridges the gap between fixed tissue and RNA analysis. The photolinker serves as a mediator that can be activated by light to release the active capturing moiety, enabling RNA capture on fixed tissue without direct interference from the fixation process.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conventional mRNA isolation tools are used, then mRNA detection is improved, but the ability to detect all RNA species and perform multiplexed analysis deteriorates

Engineering Contradiction:
ImprovemRNA detectionVSAvoidRNA species coverage and multiplexing capability
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The caged molecule is designed with a universal capturing mechanism that can bind to all RNA species through the exposed moiety, not just polyA+ mRNA. The system can be configured with different capturing moieties to detect various RNA types (mRNA, microRNA, lincRNA, etc.) and can perform multiplexed analysis by detecting multiple targets simultaneously within the same cell.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent changes the state of the capturing molecule from caged (inactive) to uncaged (active) through photolinker activation. This parameter change enables the molecule to transition from a delivery-optimized state to a detection-optimized state, allowing it to capture and detect diverse RNA species with high versatility.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If single cells are isolated for analysis, then molecular fingerprinting is improved, but the systemic regulation context is lost

Engineering Contradiction:
Improvemolecular fingerprintingVSAvoidsystemic regulation context
Core Design Contradiction:
Measurement precisionVSLoss of information

Solution Approach 1:

The caged molecule is administered to the tissue sample before isolation or sectioning, allowing it to distribute throughout the tissue and reach target cells in their native context. This preliminary administration ensures that when cells are later isolated or sectioned, the capturing moieties are already in position to capture RNA molecules, preserving the systemic context information.

Inventive Principle:
Principle #10Preliminary action

4Productivity

If polyA+ mRNA enrichment is used, then mRNA isolation efficiency is improved, but the ability to capture all RNA species deteriorates

Engineering Contradiction:
ImprovemRNA isolation efficiencyVSAvoidtotal RNA capture capability
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The caged molecule employs a universal capturing mechanism that does not rely on polyA tail enrichment. Instead, it uses a photolinker-caged moiety that can be designed to capture various RNA species through different mechanisms (hybridization, binding to specific sequences or structures), enabling total RNA capture while maintaining high efficiency.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the comprehensive detection and analysis of nucleic acid fingerprints from single cells and subcellular compartments, overcoming the limitations of existing methods by capturing a wide range of RNA species and maintaining RNA integrity in fixed samples.

Implementation Method 1

irradiation of ruthenium-based photolinker exposes the antisense oligonucleotide thereby allowing the antisense oligonucleotide to hybridize with a nucleic acid

Methodology Applied
Scientific EffectPhotodissociation: Photodissociation

Data Source

PatentUS20240166678A1Transcriptome In Vivo Analysis (TIVA) and Transcriptome In Situ Analysis (TISA)
Publication Date: 2024.05.23 THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
  • US20240166678A1 patent drawing
  • US20240166678A1 patent drawing
  • US20240166678A1 patent drawing

AI summary

Compositions and methods of capturing one or more nucleic acid molecules of a cell or subcellular compartment are described. In certain aspects, the compositions comprise a caged molecule comprising one or more photolinkers and an antisense oligonucleotide, which when uncaged hybridizes to a target nucleic acid molecule.